Mechanisms mediating NTS P2x receptor-evoked hypotension: cardiac output vs. total peripheral resistance

Department of Physiology, Wayne State University School of Medicine, Detroit, Michigan 48201 We have previously shown that P 2x purinoceptor activation in the subpostremal nucleus tractus solitarius (NTS) produces dose-dependent decreases in mean arterial pressure (MAP), heart rate, efferent sympath...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 2001-11, Vol.281 (5), p.H2198-H2203
Hauptverfasser: Kitchen, Amy M, Collins, Heidi L, DiCarlo, Stephen E, Scislo, Tadeusz J, O'Leary, Donal S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Department of Physiology, Wayne State University School of Medicine, Detroit, Michigan 48201 We have previously shown that P 2x purinoceptor activation in the subpostremal nucleus tractus solitarius (NTS) produces dose-dependent decreases in mean arterial pressure (MAP), heart rate, efferent sympathetic nerve activity, and significant peripheral vasodilation. However, the relative roles of cardiac output (CO) and total peripheral resistance (TPR) in mediating this depressor response are unknown. Bradycardia does not necessarily result in decreased CO, because, with the greater filling time, stroke volume may increase such that CO may be unchanged. We measured changes in CO (via a chronically implanted flow probe on the ascending aorta) and MAP in -chloralose- and urethane-anesthetized male Sprague-Dawley rats in response to microinjection of the selective P 2x purinoceptor agonist , -methylene ATP (25 and 100 pmol/50 nl) into the subpostremal NTS. TPR was calculated as MAP/CO. At the low dose of NTS P 2x purinoceptor agonist, the reduction in MAP was primarily mediated by reductions in TPR ( 31.3 ± 3.3%), not CO ( 8.7 ± 1.7%). At the high dose, both CO ( 34.4 ± 6.6%) and TPR ( 40.2 ± 2.5%) contribute to the reduction in MAP. We conclude that the relative contribution of CO and TPR to the reduction in MAP evoked by NTS P 2x purinoceptor activation is dependent on the extent of P 2x purinoceptor activation. purinergic receptors; ATP; adenosine
ISSN:0363-6135
1522-1539
DOI:10.1152/ajpheart.2001.281.5.h2198